Milestone Pharmaceuticals... (MIST)
NASDAQ: MIST
· Real-Time Price · USD
1.78
0.06 (3.49%)
At close: Jun 17, 2025, 10:54 AM
3.49% (1D)
| Bid | 1.78 |
| Market Cap | 95.43M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -31.16M |
| EPS (ttm) | -0.77 |
| PE Ratio (ttm) | -2.32 |
| Forward PE | -1.7 |
| Analyst | Buy |
| Ask | 1.79 |
| Volume | 260,640 |
| Avg. Volume (20D) | 2,273,773 |
| Open | 1.69 |
| Previous Close | 1.72 |
| Day's Range | 1.69 - 1.79 |
| 52-Week Range | 0.63 - 2.75 |
| Beta | 0.92 |
About MIST
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol MIST
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for MIST stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 months ago
-60.89%
Milestone Pharmaceuticals shares are trading lower...
Unlock content with
Pro Subscription
9 months ago
+2.86%
Milestone Pharmaceuticals shares are trading higher after Rodman & Renshaw initiated coverage on the stock with a Buy rating and announced a $9 price target.
2 months ago · seekingalpha.com
Milestone Pharmaceuticals: A Compelling Value Proposition For Patients And PayersIn December 2023, Milestone Pharmaceuticals received an RTF letter from the FDA for insufficient TEAE data in their NDA filing, which precipitated a rapid decline in its share price. With an upcoming ...